Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Albert

Showing results (251-260 of 437) with videos related to

Pageof 44
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 30, 2007
Synthesis and biological evaluation of 5-substituted 1,4-dihydroindeno[1,2-c]pyrazoles as multitargeted receptor tyrosine kinase inhibitorsIrini Akritopoulou-Zanze, Daniel H Albert, Peter F Bousquet, et al.
Haematologica|October 29, 2013
Treosulfan-based conditioning regimen for children and adolescents with hemophagocytic lymphohistiocytosisKai Lehmberg, Michael H Albert, Rita Beier, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2014
Beneficial IFN-α treatment of tumorous herpes simplex blepharoconjunctivitis in dedicator of cytokinesis 8 deficiencyCihan Papan, Beate Hagl, Valerie Heinz, et al.
European Cytokine Network|February 9, 2006
Intracellular T-cell cytokine levels are age-dependent in healthy children and adultsFlorian Hoffmann, Michael H Albert, Stephan Arenz, et al.
Bone Marrow Transplantation|August 18, 2009
Successful SCT for Nijmegen breakage syndromeM H Albert, A R Gennery, J Greil, et al.
Journal of Hepatology|October 22, 2008
ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograftViraj J Jasinghe, Zhigang Xie, Jianbiao Zhou, et al.
Public Health Action|September 25, 2015
Countrywide roll-out of Xpert(®) MTB/RIF in Swaziland: the first three years of implementationW Sikhondze, T Dlamini, D Khumalo, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|July 1, 1997
Ex vivo inhibition of beta-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonistD H Albert, T J Magoc, S D Menacherry, et al.
Journal of AOAC International|July 1, 1995
U.S. Food and Drug Administration pesticide program: incidence/level monitoring of domestic and imported pears and tomatoesR R Roy, R H Albert, P Wilson, et al.
Molecular Cancer Research : MCR|February 26, 2009
Large-scale production and characterization of novel CD4+ cytotoxic T cells with broad tumor specificity for immunotherapyClaudia Jursik, Michaela Prchal, Regina Grillari-Voglauer, et al.
Pageof 44

Showing results (251-260 of 437) with videos related to

Sort By:
Pageof 44
Bioorganic & Medicinal Chemistry Letters|March 30, 2007
Synthesis and biological evaluation of 5-substituted 1,4-dihydroindeno[1,2-c]pyrazoles as multitargeted receptor tyrosine kinase inhibitorsIrini Akritopoulou-Zanze, Daniel H Albert, Peter F Bousquet, et al.
Haematologica|October 29, 2013
Treosulfan-based conditioning regimen for children and adolescents with hemophagocytic lymphohistiocytosisKai Lehmberg, Michael H Albert, Rita Beier, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2014
Beneficial IFN-α treatment of tumorous herpes simplex blepharoconjunctivitis in dedicator of cytokinesis 8 deficiencyCihan Papan, Beate Hagl, Valerie Heinz, et al.
European Cytokine Network|February 9, 2006
Intracellular T-cell cytokine levels are age-dependent in healthy children and adultsFlorian Hoffmann, Michael H Albert, Stephan Arenz, et al.
Bone Marrow Transplantation|August 18, 2009
Successful SCT for Nijmegen breakage syndromeM H Albert, A R Gennery, J Greil, et al.
Journal of Hepatology|October 22, 2008
ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograftViraj J Jasinghe, Zhigang Xie, Jianbiao Zhou, et al.
Public Health Action|September 25, 2015
Countrywide roll-out of Xpert(®) MTB/RIF in Swaziland: the first three years of implementationW Sikhondze, T Dlamini, D Khumalo, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|July 1, 1997
Ex vivo inhibition of beta-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonistD H Albert, T J Magoc, S D Menacherry, et al.
Journal of AOAC International|July 1, 1995
U.S. Food and Drug Administration pesticide program: incidence/level monitoring of domestic and imported pears and tomatoesR R Roy, R H Albert, P Wilson, et al.
Molecular Cancer Research : MCR|February 26, 2009
Large-scale production and characterization of novel CD4+ cytotoxic T cells with broad tumor specificity for immunotherapyClaudia Jursik, Michaela Prchal, Regina Grillari-Voglauer, et al.
Pageof 44